A Randomised trial of Adjuvant Chemotherapy (ECF) in Biliary Cancer

ISRCTN ISRCTN18496239
DOI https://doi.org/10.1186/ISRCTN18496239
Secondary identifying numbers RMH E/C 1325
Submission date
19/08/2002
Registration date
19/08/2002
Last edited
26/03/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr - -
Scientific

UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleA Randomised trial of Adjuvant Chemotherapy (ECF) in Biliary Cancer
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedBiliary tract cancer
InterventionTwo Arms:
1. ECF - 5-Fluorouracil (5FU) 200 mg/m2 continuous infusion daily Epirubicin 50 mg/m2 3 weekly IV bolus Cisplatin 60 mg/m2 3 weekly
2. No treatment
Intervention typeOther
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2000
Completion date28/02/2002

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Histological confirmed carcinoma of biliary tract or gall bladder
2. Disease considered to have been completely resected
3. No metastases on staging
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2000
Date of final enrolment28/02/2002

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

UKCCCR Register Co-ordinator
London
NW1 2DA
United Kingdom

Sponsor information

Royal Marsden Hospital (UK)
Hospital/treatment centre

Downs Road
Sutton
SM2 5PT
England
United Kingdom

Phone +44 (0)20 8661 3156
Email david.cunningham@rmh.nhs.uk
ROR logo "ROR" https://ror.org/034vb5t35

Funders

Funder type

Hospital/treatment centre

Royal Marsden Hospital (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/1995 26/03/2020 Yes No

Editorial Notes

26/03/2020: Publication reference added.